F
$ Value
$136K
Shares
1,775
Price
$77
Filed
Feb 17
Insider
Name
Gutwerg Ori
Title
SVP, GENERICS
CIK
0001846478
Roles
Officer
Transaction Details
Transaction Date
2026-02-12
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
77,982
Footnotes
Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,917 shares of restricted stock, the grant of which was previously reported on February 18, 2025. | Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,691 shares of restricted stock, the grant of which was previously reported on February 16, 2024.
Filing Info
Gutwerg Ori's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-07 | ANIP | F | $245K |
| 2026-03-03 | ANIP | ▼ | $158K |
| 2026-02-28 | ANIP | F | $164K |
| 2026-02-26 | ANIP | A | $1.0M |
| 2026-02-14 | ANIP | F | $146K |
| 2026-02-12 | ANIP | F | $136K |
| 2026-02-11 | ANIP | F | $325K |
| 2025-08-12 | ANIP | ▼ | $508K |
| 2025-05-15 | ANIP | ▼ | $53K |
Other Insiders at ANIP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
|
— | $357K | 2026-03-11 |
|
CAREY STEPHEN P.
SVP & CFO
|
— | $552K | 2026-03-07 |
| Walsh Patrick D | — | $445K | 2026-03-03 |
|
Lalwani Nikhil
PRESIDENT & CEO
|
— | — | 2026-03-07 |
|
Gutwerg Ori
SVP, GENERICS
|
— | $158K | 2026-03-07 |
|
Mutz Christopher
HEAD OF RARE DISEASE
|
— | $1.6M | 2026-03-13 |
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
|
— | — | 2026-02-26 |
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
|
— | — | 2026-02-28 |
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
|
— | $114K | 2026-04-13 |
|
Davis Krista
SVP, CHIEF HR OFFICER
|
— | $785K | 2026-03-09 |